Magnesium Oxide



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Blood Magnesium Decreased 42.9%
Hypomagnesaemia 28.6%
Mineral Supplementation 14.3%
Plasma Cell Myeloma 14.3%
Anaphylactic Reaction 11.1%
Fatigue 11.1%
Hypomagnesaemia 11.1%
Hypotension 11.1%
Liver Transplant Rejection 11.1%
Plasma Cell Myeloma 11.1%
Pruritus 11.1%
Renal Failure Acute 11.1%
Vomiting 11.1%
Secondary
Drug Use For Unknown Indication 22.9%
Constipation 14.5%
Product Used For Unknown Indication 13.2%
Schizophrenia 6.9%
Prophylaxis 5.9%
Pain 4.6%
Hypertension 4.5%
Infection Prophylaxis 4.2%
Delirium 3.6%
Eczema 3.1%
Parkinson's Disease 2.4%
Dyschezia 2.1%
Epilepsy 1.9%
Hyperlipidaemia 1.7%
Autism 1.5%
Herpes Zoster 1.5%
Renal Transplant 1.4%
Rheumatoid Arthritis 1.4%
Compression Fracture 1.3%
Glioblastoma 1.3%
Urinary Retention 26.3%
Somnolence 11.6%
Pyrexia 6.3%
Vomiting 6.3%
Diarrhoea 4.2%
Eosinophilia 4.2%
Staphylococcal Infection 4.2%
Ventricular Tachycardia 4.2%
Cardiac Failure Acute 3.2%
Granulocytopenia 3.2%
Liver Disorder 3.2%
Rash 3.2%
Weight Decreased 3.2%
White Blood Cell Count Decreased 3.2%
White Blood Cell Count Increased 3.2%
Abortion Spontaneous 2.1%
Blood Creatinine Increased 2.1%
Blood Urea Increased 2.1%
Cystitis 2.1%
Drug Tolerance 2.1%
Concomitant
Product Used For Unknown Indication 25.0%
Drug Use For Unknown Indication 16.9%
Constipation 9.8%
Prophylaxis 9.6%
Hypertension 7.0%
Rheumatoid Arthritis 3.9%
Pain 3.7%
Insomnia 3.7%
Diabetes Mellitus 3.1%
Depression 1.9%
Multiple Myeloma 1.9%
Gastritis 1.9%
Nausea 1.8%
Cancer Pain 1.7%
Osteoporosis 1.6%
Premedication 1.5%
Infection Prophylaxis 1.4%
Schizophrenia 1.2%
Colorectal Cancer 1.2%
Non-small Cell Lung Cancer 1.1%
Vomiting 14.0%
White Blood Cell Count Decreased 10.7%
Pyrexia 8.3%
Pneumonia 8.2%
Weight Decreased 5.9%
Death 5.4%
Interstitial Lung Disease 4.9%
Thrombocytopenia 4.2%
Sepsis 3.8%
White Blood Cell Count Increased 3.8%
Platelet Count Decreased 3.5%
Renal Impairment 3.2%
Nausea 3.1%
Rash 3.1%
Renal Failure Acute 3.1%
Respiratory Failure 3.1%
Urinary Tract Infection 3.1%
Weight Increased 3.0%
Somnolence 2.7%
Hepatic Function Abnormal 2.6%
Interacting
Periodontitis 21.1%
Hypertension 15.8%
Arrhythmia 10.5%
Diabetes Mellitus 10.5%
Glaucoma 10.5%
Myocardial Ischaemia 10.5%
Asthma 5.3%
Blood Cholesterol Increased 5.3%
Sarcoma 5.3%
Smoking Cessation Therapy 5.3%
Dyspnoea 25.0%
Nausea 25.0%
Nocturia 25.0%
Periodontitis 25.0%